4//SEC Filing
PARACKA DANIEL 4
Accession 0001209499-03-000112
CIK 0001116613other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:13 PM ET
Size
12.4 KB
Accession
0001209499-03-000112
Insider Transaction Report
Form 4
PARACKA DANIEL
Director
Transactions
- Other
Common Stock
2003-08-22−1,700→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2003-08-22−15,000→ 0 totalExercise: $4.95From: 2004-05-27Exp: 2013-05-27→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Pursuant to the merger of Ribapharm Inc. and Rx Acquisition Corp. on August 22, 2003, these shares were converted into the right to receive $6.25 per share in cash.
- [F2]Under the terms of Ribapharm Inc.'s 2002 Stock Option and Award Plan, the reporting person may receive either a) cash or b) options to purchase common stock of ICN Pharmaceuticals, Inc. in connection with the merger of Ribapharm Inc.
Issuer
RIBAPHARM INC
CIK 0001116613
Entity typeother
Related Parties
1- filerCIK 0001220284
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:13 PM ET
- Size
- 12.4 KB